PulseOn
- Company typePrivate
- Founded2012
- HeadquartersNeuchâtel, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
PulseOn firmographics
Firmographics- Name
- PulseOn
- Legal name
- PulseOn Oy
- Website
- https://pulseon.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
PulseOn industry classification
Industry- Product category
- Medical Wearable Cardiac Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Other Measuring and Controlling Device Manufacturing (334519)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Electrophysiology (Heart Rhythm) (HLAKABAC)
Keywords
Where PulseOn is headquartered
LocationHeadquarters
- HQ city
- Neuchâtel
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
PulseOn business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Arrhythmia Monitor System (AMS-1): Sale of wrist-worn medical device system consisting of Arrhythmia Monitor (AM-1), Charging Dock (CD-1), optional Gateway (GW-1), and Data Management Service (DMS-1). The system is a CE-certified MDR Class IIa medical device for professional medical use.
- Data Management Service (Cloud): Secure cloud service with web interface for healthcare professionals, including automated arrhythmia classification and data storage. Sold as part of the complete arrhythmia monitoring solution.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Complete arrhythmia monitoring system for healthcare providers |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
PulseOn product offering
Product offeringCore offering
PulseOn sells the Arrhythmia Monitor System (AMS-1), a CE-certified MDR Class IIa medical device system for healthcare providers. The system comprises a wrist-worn device (AM-1) with continuous PPG optical heart rate monitoring and on-demand ECG measurement, a charging dock (CD-1), an optional home gateway (GW-1) for remote data transfer, and a cloud-based Data Management Service (DMS-1) with automated arrhythmia classification for healthcare professionals.
Product overview
PulseOn offers the PulseOn Arrhythmia Monitor System (AMS-1), a complete medical device solution for professional arrhythmia detection and monitoring. The system comprises the Arrhythmia Monitor Wrist Device (AM-1) for continuous PPG-based heart rate monitoring and on-demand ECG measurements, the Charging Dock (CD-1) for device charging and PC data transfer, and the optional Gateway (GW-1) for real-time home data transfer. All device data flows to the Data Management Service (DMS-1), a cloud-based platform providing secure storage, automated arrhythmia classification, and a web interface for healthcare professionals to review pre-analyzed results for faster diagnosis. The system is designed and manufactured in Finland, CE certified under MDR Class IIa.
Differentiator
Problem solved
Functional benefit
Products and services
- PulseOn Arrhythmia Monitor System (AMS-1) Complete arrhythmia monitoring system combining a CE-certified wrist-worn device with continuous PPG optical heart rate monitoring and instant ECG measurement capability, paired with a cloud-based Data Management Service for healthcare professionals to screen, detect, and monitor atrial fibrillation and other cardiac arrhythmias.
- PulseOn Arrhythmia Monitor Wrist Device (AM-1) Wrist-worn medical device that continuously measures heartbeats via optical PPG sensors during periods of no motion, detects cardiac rhythm irregularities, and allows patients to take instant 35-second ECG recordings by placing their other hand on the device.
- PulseOn Charging Dock (CD-1) Charging dock for recharging the wrist device in under 2 hours; also enables data connection with a computer to transfer results and configure the device for individual patients.
- PulseOn Gateway (GW-1) Optional home device enabling easy data transfer from the wrist device to the Data Management Service, allowing nearly real-time remote monitoring of patients from a distance as an alternative to manual data syncing.
- PulseOn Data Management Service (DMS-1) Secure cloud-based service with an easy web interface for healthcare professionals providing storage, automated arrhythmia classification, and practical tools for interpreting results to enable faster diagnosis and treatment decisions. Available in Europe, UK, Middle East, Singapore, and Australia.
Quantifiable outcome
- 95.5% sensitivity and 99.2% specificity for AF detection in population over 50 years
- +4 more outcomes
Companies that use PulseOn
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
PulseOn technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
PulseOn partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Tampere Heart Hospital and Tampere UniversitycoreClinical collaboration for validation studies and research on PulseOn arrhythmia detection technology. Joint research projects including published clinical trial article in Frontiers in Cardiovascular Medicine (2023). The collaboration validated the wrist-worn PPG+ECG solution for atrial fibrillation detection in ambulatory settings.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
PulseOn competitors and assessment
Company assessmentDirect peers
- Withings: Withings ScanWatch and Move ECG combine wrist-worn optical heart rate with single-lead ECG for AF detection, overlapping PulseOn's PPG+ECG wrist device proposition in consumer and prosumer channels.
- iRhythm Technologies: iRhythm's Zio long-term continuous ECG patch is the leading direct competitor in ambulatory arrhythmia detection, selling to the same cardiology and hospital customers with a similar clinical value proposition of replacing short-duration Holter monitoring.
- AliveCor: AliveCor's KardiaMobile single-lead ECG device targets AF detection with similar sensitivity/specificity claims, addressing overlapping clinicians and patient populations through a hardware-plus-cloud subscription model.
- Qompium (FibriCheck): FibriCheck delivers PPG-based AF detection through smartphone cameras with regulatory clearances and hospital partnerships across Europe, directly overlapping PulseOn's remote arrhythmia screening use case and target buyers.
Emerging players
- HeartBeam: HeartBeam is an early-stage competitor building a credit-card-sized 3-lead ECG for ambulatory rhythm assessment, pursuing a similar clinical-grade remote cardiac monitoring opportunity with comparable regulatory strategy.
- Peerbridge Health: Peerbridge's Peerbridge ECG is a multi-lead wearable patch for continuous ambulatory rhythm monitoring, addressing the same Holter-replacement opportunity as PulseOn with a different form factor.
- HeartcoR Solutions: HeartcoR focuses on cloud-based cardiac arrhythmia analytics and remote monitoring services that can complement or compete with PulseOn's Data Management Service for hospitals seeking outsourced rhythm reporting.
Broad incumbents
- Apple (Apple Watch ECG): Apple Watch's FDA-cleared ECG feature represents a broad incumbent in consumer heart rhythm monitoring, raising consumer awareness of AF detection and shaping clinician expectations that PulseOn's clinical-grade device must surpass.
- Philips (BioTel): Philips BioTel is a broad incumbent in cardiac diagnostics and remote monitoring with mobile cardiac telemetry and Holter offerings, competing head-to-head with PulseOn for hospital and cardiology contracts as part of a much larger portfolio.
- Boston Scientific (Preventice Solutions): Boston Scientific acquired Preventice BodyGuardian, a major ambulatory ECG monitoring service operating the same hospital channel as PulseOn with materially larger scale and clinical integration.
Market position
Strengths5 records
Weaknesses3 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
PulseOn social profiles
Digital presencePulseOn compliance and trust
Trust signalCompliance3 records
PulseOn financial estimates
Financial estimateRevenue estimate
Valuation estimate
PulseOn leadership team
Management profileNumber of profiles
Profiles12 records
PulseOn funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PulseOn M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PulseOn
What does PulseOn do?
PulseOn sells the Arrhythmia Monitor System (AMS-1), a CE-certified MDR Class IIa medical device system for healthcare providers. The system comprises a wrist-worn device (AM-1) with continuous PPG optical heart rate monitoring and on-demand ECG measurement, a charging dock (CD-1), an optional home gateway (GW-1) for remote data transfer, and a cloud-based Data Management Service (DMS-1) with automated arrhythmia classification for healthcare professionals.
Is PulseOn a public or private company?
PulseOn is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PulseOn founded?
PulseOn was founded in 2012. It employs 11 to 50 people.
Where is PulseOn based?
PulseOn is headquartered in Neuchâtel, Switzerland, in the Europe region.
How does PulseOn make money?
Two revenue lines are on record. Arrhythmia Monitor System (AMS-1) is the primary driver. The others are data Management Service (Cloud).
Who are PulseOn's main competitors?
Direct peers on record are Withings, iRhythm Technologies, AliveCor and Qompium (FibriCheck). Emerging players are HeartBeam, Peerbridge Health and HeartcoR Solutions. Broad incumbents are Apple (Apple Watch ECG), Philips (BioTel) and Boston Scientific (Preventice Solutions).
Does PulseOn have an API?
No public API is recorded for PulseOn.
What industry is PulseOn in?
PulseOn's product category is Medical Wearable Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.